FIGO Stage III and IV Ovarian Cancer
2 clinical trials · Condition
◉ Watch FIGO Stage III and IV Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer (NCT07322094) | TORL Biotherapeutics, LLC | 2025-12-10 |
| IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer (NCT03054909) | Masonic Cancer Center, University of Minnesota | 2017-09-19 |
Track FIGO Stage III and IV Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.